We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
35 hedge funds and large institutions have $68.9M invested in Corvus Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
5.11% less ownership
Funds ownership: 83% → 77.89% (-5.1%)
22% less funds holding
Funds holding: 45 → 35 (-10)
24% less capital invested
Capital invested by funds: $91M → $68.9M (-$22M)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
35
Holders Change
-10
Holders Change %
-22.22%
% of All Funds
0.77%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
3
Increased
14
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$3.68M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$1.14M |
| 3 |
O
OrbiMed
New York
|
+$847K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$363K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$122K |
